JP2012503024A5 - - Google Patents

Download PDF

Info

Publication number
JP2012503024A5
JP2012503024A5 JP2011528081A JP2011528081A JP2012503024A5 JP 2012503024 A5 JP2012503024 A5 JP 2012503024A5 JP 2011528081 A JP2011528081 A JP 2011528081A JP 2011528081 A JP2011528081 A JP 2011528081A JP 2012503024 A5 JP2012503024 A5 JP 2012503024A5
Authority
JP
Japan
Prior art keywords
peptidomimetic macrocycle
amino acid
peptidomimetic
independently
macrocycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011528081A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012503024A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/057927 external-priority patent/WO2010034028A1/en
Publication of JP2012503024A publication Critical patent/JP2012503024A/ja
Publication of JP2012503024A5 publication Critical patent/JP2012503024A5/ja
Withdrawn legal-status Critical Current

Links

JP2011528081A 2008-09-22 2009-09-22 ペプチド模倣大環状分子 Withdrawn JP2012503024A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9917208P 2008-09-22 2008-09-22
US61/099,172 2008-09-22
PCT/US2009/057927 WO2010034028A1 (en) 2008-09-22 2009-09-22 Peptidomimetic marcrocycles

Publications (2)

Publication Number Publication Date
JP2012503024A JP2012503024A (ja) 2012-02-02
JP2012503024A5 true JP2012503024A5 (enExample) 2012-05-24

Family

ID=41581947

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011528081A Withdrawn JP2012503024A (ja) 2008-09-22 2009-09-22 ペプチド模倣大環状分子

Country Status (8)

Country Link
US (1) US20120115783A1 (enExample)
EP (1) EP2342214A1 (enExample)
JP (1) JP2012503024A (enExample)
CN (1) CN102197046A (enExample)
AU (1) AU2009294871A1 (enExample)
BR (1) BRPI0918833A2 (enExample)
CA (1) CA2737916A1 (enExample)
WO (1) WO2010034028A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105061577A (zh) 2006-12-14 2015-11-18 爱勒让治疗公司 双巯基大环化系统
ES2648687T3 (es) 2007-02-23 2018-01-05 Aileron Therapeutics, Inc. Péptidos macrocíclicos unidos a triazol
KR20160061439A (ko) 2007-03-28 2016-05-31 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 스티칭된 폴리펩티드
WO2010033879A2 (en) 2008-09-18 2010-03-25 New York University Inhibiting interaction between hif-1a and p300/cbp with hydrogen bond surrogate-based helices
EP2342222B1 (en) 2008-09-22 2018-03-21 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
CN102223891A (zh) 2008-11-24 2011-10-19 爱勒让治疗公司 具有改善性质的拟肽大环化合物
US9175047B2 (en) 2009-01-14 2015-11-03 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
CN102712675A (zh) 2009-09-22 2012-10-03 爱勒让治疗公司 拟肽大环化合物
WO2012021875A1 (en) * 2010-08-13 2012-02-16 Aileron Therapeutics, Inc. Peptidomimetic macrocycles with triazole linkers
EP2627662B1 (en) 2010-10-13 2015-09-16 Bristol-Myers Squibb Company Methods for preparing macrocycles and macrocycle stabilized peptides
JP6342808B2 (ja) 2011-10-18 2018-06-13 エイルロン セラピューティクス,インコーポレイテッド ペプチドミメティック大環状化合物
CN108912211A (zh) 2012-02-15 2018-11-30 爱勒让治疗公司 三唑交联的和硫醚交联的拟肽大环化合物
EP3769776A1 (en) * 2012-02-15 2021-01-27 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
BR112015009470A2 (pt) 2012-11-01 2019-12-17 Aileron Therapeutics Inc aminoácidos dissubstituídos e seus métodos de preparação e uso
WO2014113792A1 (en) 2013-01-19 2014-07-24 New York University Hydrogen-bond surrogate peptides and peptidomimetics for p53 reactivation
WO2014138429A2 (en) * 2013-03-06 2014-09-12 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and use thereof in regulating hif1alpha
SG10201902594QA (en) 2014-09-24 2019-04-29 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof
EP3197477A4 (en) 2014-09-24 2018-07-04 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and formulations thereof
AU2016235424A1 (en) 2015-03-20 2017-10-05 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
WO2017004548A1 (en) 2015-07-01 2017-01-05 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
CN108368161A (zh) 2015-09-10 2018-08-03 艾瑞朗医疗公司 作为mcl-1调节剂的拟肽大环化合物
EP4023295A1 (en) 2020-12-29 2022-07-06 IDP Discovery Pharma, S.L. Vegf-regulating peptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2332968T3 (pl) * 2003-11-05 2017-08-31 Dana-Farber Cancer Institute, Inc. Stabilizowane alfa-helikalne peptydy i ich zastosowania
CA2576293C (en) * 2004-07-12 2016-10-04 Nicola J. Mabjeesh Agents capable of downregulating an msf-a-dependent hif-1alpha and use thereof in cancer treatment
WO2008045238A2 (en) * 2006-10-05 2008-04-17 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
CN105061577A (zh) * 2006-12-14 2015-11-18 爱勒让治疗公司 双巯基大环化系统
ES2648687T3 (es) * 2007-02-23 2018-01-05 Aileron Therapeutics, Inc. Péptidos macrocíclicos unidos a triazol

Similar Documents

Publication Publication Date Title
JP2012503024A5 (enExample)
JP2013505300A5 (enExample)
JP2012510430A5 (enExample)
JP2012515172A5 (enExample)
JP2013535514A5 (enExample)
JP2015110654A5 (enExample)
JP2012515778A5 (enExample)
JP2022095872A5 (enExample)
JP2016199546A5 (enExample)
RU2017145921A (ru) Пептидомиметические макроциклы
JP2014530868A5 (enExample)
JP2019521139A5 (enExample)
JP6297969B2 (ja) 部位特異的モノpeg化エキセンジン類似体およびその調製方法
TW202332683A (zh) 介白素-23受體之肽抑制劑
JP2015522576A5 (enExample)
DE69130071T2 (de) Zusammensetzung verwendbar als therapeutisches mittel gegen chronische virale leberkrankheiten
JP2011511076A5 (enExample)
TW201209062A (en) Amide based glucagon superfamily peptide prodrugs
JP2019043957A5 (enExample)
JP2018515101A5 (enExample)
DE602005021858D1 (de) Peptide der amylin familie, verfahren zu deren herstellung und verwendung
JP2013520986A5 (enExample)
CN1133047A (zh) 治疗用肽衍生物
JP2016511751A5 (enExample)
EP2729493A1 (en) Novel compounds and their effects on feeding behaviour